Asenapine

Antagonist at D2, 5-HT2A, alpha-1, alpha-2, H1 receptors; sublingual administration

• ·Treatment Resistant Schizophrenia
• ·Treatment Resistant Bipolar Disorder
• ·Stroke
• ·Bipolar Disorder
• ·Schizophrenia

No curated interaction pairs are recorded for Asenapine. This is not a statement that none exist — check a full interaction reference before combining.

• Somnolence
• Oral hypoesthesia
• Dizziness
• Weight gain

Half-life

24 hours

Protein binding

95%

Metabolised by

CYP1A2

Not recorded for Asenapine. Absence here means this database does not hold a category — not that the drug is safe in pregnancy or breastfeeding.